CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum

21 May 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update

14 May 2025 13:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical Data Featured in Six Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

09 May 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025

08 May 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical to Participate in a Fireside Chat at the Citizens Life Sciences Conference

01 May 2025 04:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

09 Apr 2025 06:48:20 By NetDania Notify

Clearside Biomedical to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference

01 Apr 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

27 Mar 2025 13:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical Announces Six Abstracts Accepted for Presentation at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

24 Mar 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical’s Lead Clinical Program CLS-AX in Wet AMD and Suprachoroidal Delivery Platform Highlighted at the 2025 Wet AMD & Diabetic Eye Disease Summit

20 Mar 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update on Thursday, March 27, 2025

12 Mar 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD

06 Mar 2025 04:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

03 Mar 2025 12:58:05 By NetDania Notify

Clearside Biomedical’s Asia-Pacific Partner, Arctic Vision, Announced Acceptance of its New Drug Application for ARCATUS® for Regulatory Review in China for the Treatment of Uveitic Macular Edema

20 Feb 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical Announces Additional Data from the CLS-AX ODYSSEY Phase 2b Trial Presented at the Angiogenesis, Exudation, and Degeneration 2025 Meeting

10 Feb 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical to Participate in Fireside Chat at the Oppenheimer 35th Annual Healthcare Life Sciences Virtual Conference

04 Feb 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical Announces Multiple Medical Meeting Presentations Focused on the Advantages of Suprachoroidal Delivery and Key Differentiators in its CLS-AX Clinical Program

28 Jan 2025 04:05:00 By Nasdaq GlobeNewswire

Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore

22 Jan 2025 04:05:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK

20 Dec 2024 06:46:04 By NetDania Notify

Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye

19 Dec 2024 04:05:00 By Nasdaq GlobeNewswire